Free Trial

Analysts Set Addus HomeCare Corporation (NASDAQ:ADUS) PT at $142.57

Addus HomeCare logo with Medical background

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) has been given an average recommendation of "Buy" by the eight research firms that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $142.57.

A number of equities analysts have recently issued reports on ADUS shares. JMP Securities reiterated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Wednesday, July 16th. Macquarie reissued an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Finally, Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th.

View Our Latest Report on ADUS

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president directly owned 7,796 shares of the company's stock, valued at approximately $896,540. This represents a 20.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 4.60% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

Hedge funds have recently made changes to their positions in the company. Alliancebernstein L.P. boosted its stake in shares of Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after purchasing an additional 91 shares during the last quarter. First Hawaiian Bank boosted its position in shares of Addus HomeCare by 2.0% in the first quarter. First Hawaiian Bank now owns 4,898 shares of the company's stock worth $484,000 after acquiring an additional 95 shares during the last quarter. Maryland State Retirement & Pension System boosted its position in shares of Addus HomeCare by 1.9% in the second quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company's stock worth $615,000 after acquiring an additional 101 shares during the last quarter. Natixis boosted its position in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after acquiring an additional 132 shares during the last quarter. Finally, Sheets Smith Wealth Management boosted its position in shares of Addus HomeCare by 1.9% in the second quarter. Sheets Smith Wealth Management now owns 7,413 shares of the company's stock worth $854,000 after acquiring an additional 141 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Price Performance

Addus HomeCare stock traded up $1.68 during mid-day trading on Friday, hitting $110.39. The stock had a trading volume of 95,931 shares, compared to its average volume of 165,577. The firm has a market capitalization of $2.03 billion, a P/E ratio of 24.92, a P/E/G ratio of 1.54 and a beta of 0.81. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20. The firm's 50 day moving average is $112.35 and its 200 day moving average is $109.68. Addus HomeCare has a one year low of $88.96 and a one year high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business's revenue was up 20.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.21 EPS. On average, sell-side analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

About Addus HomeCare

(Get Free Report

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines